icon-    folder.gif   Conference Reports for NATAP  
 
  Conference on Retroviruses
and Opportunistic Infections (CROI)
Boston, Massachusetts
March 4-7, 2018
Back grey_arrow_rt.gif
 
 
 
Impact of Raltegravir Intensification of first-line ART on IRIS in the REALITY trial (Reduction of EArly mortaLITY in HIV-infected adults and children starting ART)
 
 
  Reported by Jules Levin
CROI 2018 March 4-7 Boston, MA
 
Diana M Gibb on behalf of the REALITY trial team

0305181

0305182

0305183

0305184

0305185

0305186

0305187

0305188

0305189

03051810

03051811

03051812